Simmons Bank Sells 96 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Simmons Bank cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 14,549 shares of the medical equipment provider’s stock after selling 96 shares during the quarter. Simmons Bank’s holdings in Intuitive Surgical were worth $7,594,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp grew its stake in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. FMR LLC boosted its holdings in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC grew its position in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC increased its stake in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares during the last quarter. Finally, Baillie Gifford & Co. lifted its position in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,720,023. This represents a 2.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,240 shares of company stock worth $3,529,040. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $573.74 on Wednesday. The firm has a market cap of $204.35 billion, a P/E ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. The firm’s fifty day moving average is $567.01 and its 200-day moving average is $527.27. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Finally, Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.